Suprasorb® Liquacel Ag

Suprasorb Liquacel Ag offers excellent absorption while maintaining a stable structure thanks to its blend of sodium carboxymethyl cellulose (CMC) fibres and Lyocell fibres.

Not only is the unique silver nanotechnology effective against biofilm1) and a broad spectrum of pathogens such as MRSA*but it also has a low cytotoxicity2) profile.

The CMC fibres promote efficient exudate management3) and help with autolytic debridement. Its stable structure prevents it from shrinking after the gel forms4) so the dressing can be removed in one piece5) .

*in vitro

How Suprasorb® Liquacel Ag stacks up

Destroys biofilm and reduces bacterial growth

Antimicrobial properties

Reduction of inflammatory signs according to VAS scale:

76% Wound odour reduction

75% Calor (overheating) reduction
71% Rudor (redness) Reduction
69% Tumor (swelling) Reduction
64% Dolor (pain) reduction
63% Functio laesa (restricted movment) reduction

In-Treatment Performance

Achieving the treatment goals:

100% prevention from infection
97% Maintaining a moist wound environment
93% Autolytic debridement
93% Prevention of maceration
88% Controlling the existing infection

Mode of action

When it comes into contact with wound exudate a gel is formed, which maintains a moist wound environment and supports autolytic debridement
The silver nanoparticles release silver ions into the dressing which activates their antimicrobial action, including against MRSA (based on in-vitro data)
Bacteria, exudate and cell debris are trapped in the dressing and removed during dressing changes

Order codes